An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA)
Completed · Phase 3
Conditions studied: Juvenile Psoriatic Arthritis, Enthesitis Related Arthritis
In brief
Optional open label, roll over extension study to investigate the efficacy and safety of secukinumab treatment in Juvenile Idiopathic Arthritis (JIA) subtypes of Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA).
Key facts
- Study ID
- NCT03769168
- Run by
- Novartis Pharmaceuticals
- People needed
- 55
- Starts
- 2019-06-07
- Expected to finish
- 2024-11-07
- Last updated by the study team
- 2025-10-16
Who can join
Age: 2 and older, up to 100. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Novartis Investigative Site — Istanbul, Turkey (Türkiye)
- St Lukes Intermountain Research Center — Boise, Idaho, United States
- Cincinnati Childrens Hospital — Cincinnati, Ohio, United States
- Legacy Emanuel Research Hospital Portland — Portland, Oregon, United States
- Novartis Investigative Site — Brussels, Belgium
- Novartis Investigative Site — Ghent, Belgium
- Novartis Investigative Site — Freiburg im Breisgau, Germany
- Novartis Investigative Site — Hamburg, Germany
- Novartis Investigative Site — Saint Augustin, Germany
- Novartis Investigative Site — Genova, GE, Italy
- Novartis Investigative Site — Naples, Italy
- Novartis Investigative Site — Krakow, Poland
- Novartis Investigative Site — Moscow, Russia
- Novartis Investigative Site — Saint Petersburg, Russia
- Novartis Investigative Site — Voronezh, Russia
- Novartis Investigative Site — Yekaterinburg, Russia
- Novartis Investigative Site — Panorama, Western Cape, South Africa
- Novartis Investigative Site — Cape Town, South Africa
- Novartis Investigative Site — Santiago de Compostela, Galicia, Spain
- Novartis Investigative Site — Valencia, Spain
- Novartis Investigative Site — Istanbul, Halkali, Turkey (Türkiye)
- Novartis Investigative Site — Istanbul, TUR, Turkey (Türkiye)
- Novartis Investigative Site — Ankara, Turkey (Türkiye)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.